Global Medical Implants Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Product;

Cardiovascular Implants, Orthopedic Implants, Dental Implants, Facial Implants, and Breast Implants

By Material;

Metallic Biomaterials, Ceramic Biomaterials, Polymers Biomaterials, and Natural Biomaterials

By Geography;

North America, Europe, Asia Pacific, Middle East & Africa, and Latin America - Report Timeline (2021 - 2031)
Report ID: Rn589710825 Published Date: May, 2025 Updated Date: June, 2025

Medical Implants Market Overview

Medical Implants Market (USD Million)

Medical Implants Market was valued at USD 92,352.20 million in the year 2024. The size of this market is expected to increase to USD 148,783.22 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 7.1%.


Global Medical Implants Market Growth, Share, Size, Trends and Forecast

*Market size in USD million

CAGR 7.1 %


Study Period2025 - 2031
Base Year2024
CAGR (%)7.1 %
Market Size (2024)USD 92,352.20 Million
Market Size (2031)USD 148,783.22 Million
Market ConcentrationMedium
Report Pages313
92,352.20
2024
148,783.22
2031

Major Players

  • Zimmer Biomet
  • CONMED Corporation
  • Boston Scientific Corporation
  • Stryker
  • Smith+Nephew

Market Concentration

Consolidated - Market dominated by 1 - 5 major players

Global Medical Implants Market

Fragmented - Highly competitive market without dominant players


The Medical Implants Market is witnessing dynamic growth, fueled by technological advancements, rising chronic disease cases, and increasing demand for both therapeutic and cosmetic implants. These devices whether placed internally or externally—are crucial in enhancing patient recovery, restoring functionality, and improving health outcomes across multiple specialties, including orthopedics, cardiology, neurology, and dentistry.

With over 60% of manufacturers now leveraging biocompatible materials, smart features, and less invasive procedures, innovation is a driving force in the industry. The movement toward personalized treatment is accelerating, as around 35% of new implants are tailored to individual anatomical and physiological needs. This customization is boosting acceptance rates, especially in orthopedic and dental procedures.

Cardiovascular implants, such as pacemakers and stents, currently represent nearly 30% of the total market, driven by the rising burden of heart-related conditions and a surge in minimally invasive cardiac surgeries. Meanwhile, orthopedic implants maintain the largest market share at over 40%, reflecting the impact of an aging population and increased demand for mobility-restoring solutions.

Outpatient and ambulatory implant surgeries have grown significantly, now accounting for about 25% of all implant procedures. Enhanced insurance access, smarter postoperative monitoring tools, and shorter recovery periods are propelling this shift. As patient preferences evolve, the market is pivoting toward implant solutions that offer enhanced performance, durability, and clinical value.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Product
    2. Market Snapshot, By Material
    3. Market Snapshot, By Region
  4. Medical Implants Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Surge in chronic disease-related implants

        2. Cutting-edge advancements in implant technologies

        3. Rapid growth in elderly patient base

        4. Demand for less invasive implant procedures

      2. Restraints
        1. Expensive implants limit patient access

        2. Lengthy and complex regulatory processes

        3. Post-implant complications and device failure

        4. Shortage of implant-trained healthcare experts

      3. Opportunities
        1. Rise in custom 3D-printed implants

        2. Adoption of AI-integrated smart implants

        3. Expanding implant use in emerging markets

        4. R&D partnerships driving innovative solutions

    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Medical Implants Market, By Product, 2021 - 2031 (USD Million)
      1. Cardiovascular Implants

      2. Orthopedic Implants

      3. Dental Implants

      4. Facial implants

      5. Breast implants

    2. Medical Implants Market, By Material, 2021 - 2031 (USD Million)
      1. Metallic Biomaterials

      2. Ceramic Biomaterials

      3. Polymers Biomaterials

      4. Natural Biomaterials

    3. Medical Implants Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Medtronic Plc
      2. Johnson and Johnson
      3. Boston Scientific Corporation
      4. Biotronik
      5. LivaNova PLC
      6. Globus Medical, Inc.
      7. NuVasive, Inc.
      8. Integra LifeSciences Holding Corporation
      9. InstitutStraumann AG
      10. Conmed Corporation
  7. Analyst Views
  8. Future Outlook of the Market